New research has shown that the ArteraAI test can help identify which men with non-metastatic high-risk prostate cancer are ...

Acclaro Medical has completed a Series B funding round, raising $23m, to spur the growth of its flagship products, UltraClear ...

Moximed has announced the treatment of the first subject in the MOTION randomised controlled trial (RCT) assessing its MISHA ...

HistoSonics' Edison histotripsy system has been granted controlled early limited market access in the UK under an Unmet ...

Helix has released a new suite of pharmacogenomics (PGx) tests, widening its portfolio in neurology and oncology.

BD is set to commence a multi-centre registry study, XTRACT, of the Rotarex Atherectomy System, for peripheral artery disease ...

The FDA has granted 510(k) clearance for Distalmotion’s DEXTER robotic surgery system to be used in adult cholecystectomies.

The CEO of Flow Neuroscience has called out the US Food and Drug Administration (FDA) for market entry delays for clinically ...

SAGA Diagnostics has commercially launched the multi-cancer molecular residual disease (MRD) platform, Pathlight, in the US.

The US structural heart occlusion (SHO) market recorded a strong 39% year-over-year revenue increase in the first quarter (Q1 ...

The US Food and Drug Administration (FDA) has granted approval for Abbott's Tendyne transcatheter mitral valve replacement ...

Danish medtech Brainreader has secured $7.3m (€6.6m) to support the market rollout of Neuroreader, its artificial ...